Clinical and Pathological Features of Hydroa Vacciniforme-Like Lymphoproliferative Disorder Along with Risk Factors Indicating Poor Prognosis
Li Chang,Chaoyin Zhang,Jingjing Lu,Jiahui Shen,Krishna Hamal,Donghua Liu
DOI: https://doi.org/10.2147/IDR.S402040
2023-03-16
Infection and Drug Resistance
Abstract:Li Chang, 1, 2 Chaoyin Zhang, 1 Jingjing Lu, 1 Jiahui Shen, 1 Krishna Hamal, 1 Donghua Liu 1, 2 1 Department of Dermatology and Venereology, the First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China; 2 Guangxi Key Laboratory of AIDS Prevention and Treatment, Nanning, People's Republic of China Correspondence: Donghua Liu, Department of Dermatology and Venereology, the First Affiliated Hospital of Guangxi Medical University, No. 6, Shuang Yong Road, Nanning, Guangxi Province, 530021, People's Republic of China, Tel +86 771-5356752, Email Purpose: To examine the clinical and pathological features, laboratory markers, therapeutic options and risk factors indicating poor prognosis of hydroa vacciniforme-like lymphoproliferative disorder (HVLPD). Patients and Methods: Seven patients with HVLPD had their clinical and pathological data collected. Immunohistochemical staining, Epstein-Barr virus-encoded RNA (EBER) in situ hybridization experiments, T-cell receptor (TCR) gene rearrangement, RT-PCR tests and the Elisa assay were carried out. Results: The main clinical manifestations were papulovesicular lesions and ulcers on the face, neck, or trunk. Five cases had systemic symptoms. Three of the deceased patients had significant facial edema, deep body necrosis, and ulceration. The pathological results demonstrated that lymphocytes infiltrated blood vessels and sweat glands in addition to the dermis and subcutaneous tissues. All patients tested positive for CD3 and EBER. Six cases tested positive for TCRβF1, but none tested positive for TCRδ. TCRγ monoclonal rearrangement, strongly positive expression of TIA-1 and a Ki67 proliferation index of 40% occurred in 3 fatal cases. When compared to the survival group, the plasma EBV DNA in the deceased group was considerably higher ( P < 0.05). IFN-γ and TNF-α cytokine levels in patients were higher than in the control group, particularly in the deceased group ( P < 0.05). The skin lesions on all patients recovered quickly underwent conservative care. Nonetheless, 3 patients passed away as the disease progressed in its latter stages. Conclusion: In our cases, the main infiltrating cells were T cells and the dominant lymphocyte subclass was αβT cells. A significant increase in lgE level, plasma EBV DNA, IFN-γ, and TNF-α cytokine levels, decreased hemoglobin level, strongly positive expression of TIA-1, high Ki67 proliferation index, and positive TCR gene rearrangement are all indicators of a poor prognosis. Keywords: hydroa vacciniforme-like lymphoproliferative disorder, hydroa vacciniforme, Epstein-Barr virus, Epstein-Barr virus-encoded RNA, risk factors Mostly prevalent in eastern Asia 1 and Latin America, 2 hydroa vacciniforme-like lymphoproliferative disorder (HVLPD) is a rare lymphoproliferative condition that is closely linked to chronic Epstein-Barr virus (EBV) infection. It is characterized by monoclonal proliferation of natural killer (NK) or T lymphocytes (T cells), with a risk of progressing to malignant lymphoma. 3,4 Its sensitivity to UVB or UVA has been thought to represent a significant pathogenic mechanism. 5 HVLPD is comparable to hydroa vacciniforme (HV), one of the rarest photosensitive reactions. It mainly occurs in children, but can also be seen in adults. Recurrent vesiculopapules in sun-exposed parts of the skin lead to ulcers and hemorrhagic scabs as the predominant signs. The outcome is an acne-like scar. Avoiding the sun can help, and for some people, it can go away on its own during puberty. 6,7 After a prolonged illness and numerous relapses, some unusual or severe HV patients may develop systemic disease with symptoms such as persistent fever, weight loss, facial edema, sun unexposed skin lesions, lymphadenopathy, hepatosplenomegaly, leukopenia, etc. In severe cases, fatal EBV-positive T-cell or NK cell lymphoma may develop. 8 Therefore, HVLPD was classified as an HV-like lymphoma (HVLL) containing the T cell receptor (TCR) clonal rearrangement gene in the 2008 WHO classification of hematopoietic and lymphoid malignancies. 9 Some people, however, can heal themselves or recover following therapy, while others develop lymphoma as a result of prognostic differences across patients. As a result, in the 2016 WHO updated classification of lymphoid malignancies, HVLL was reclassified as HVLPD. 10 According to the WHO's reclassification, HVLPD frequently presented as atypical cases with variable clinical and pathological manifestations, indicating that while clinical manifestations of the disease included invasion activity, atypical -Abstract Truncated-
pharmacology & pharmacy,infectious diseases